|
FDA Rubber-Stamps Bristol-Myers Squibb's Melanoma mAb
Genetic Engineering News FDA approved Bristol-Myers Sqibb's (BMS) monoclonal antibody Yervoy™ (ipilimumab) 3 mg/kg for the treatment of unresectable or metastatic melanoma. The firm claims Yervoy is the only approved therapy for unresectable or metastatic melanoma that has … |
More: continued here
